Parkinson's Disease, Volume 132 addresses new developments in the F33 study of this disease, highlighting how the lives of people with Parkinson’s have undergone dramatic changes in the last decade. New to this edition are chapters on the Hallmarks of clinical aspects PD throughout centuries, The motor syndrome of Parkinson disease, The non-motor features of Parkinson’s disease, The New Diagnostic Criteria for Parkinson's disease, Advances in the Clinical Differential diagnosis, Clinical assessments in PD : Scales and monitoring, Biomarkers of Parkinson’s disease: an Introduction, and the Genetics of Parkinson’s Disease: Genotype-Phenotype Correlations.
The topics discussed in this comprehensive series provide a clearer understanding of the prodromal stage, genetics, strategies, routes of treatment, and development of non-dopaminergic therapies in Parkinson's Disease, both medical and surgical.
1. Chapter Seven: Biomarkers of Parkinson's Disease: An Introduction - p. 182 2. Chapter Eight: Genetics of Parkinson's Disease: Genotype–Phenotype Correlations - p. 196 3. Chapter Nine: Imaging in Parkinson's Disease - p. 231 4. Chapter Ten: Cerebrospinal Fluid Biomarkers of Cognitive Decline in Parkinson's Disease - p. 274 5. Chapter Eleven: Hallmarks of Treatment Aspects: Parkinson's Disease Throughout Centuries Including l-Dopa - p. 294 6. Chapter Twelve: Treatment Strategies in Early Parkinson's Disease - p. 343 7. Chapter Thirteen: Treatment of Nonmotor Symptoms in Parkinson's Disease - p. 360 8. Chapter Fourteen: Treatment of Older Parkinson's Disease - p. 379 9. Chapter Fifteen: New Symptomatic Treatments for the Management of Motor and Nonmotor Symptoms of Parkinson's Disease - p. 405 10. Chapter Sixteen: Device-Aided Treatment Strategies in Advanced Parkinson's Disease - p. 452 11. Chapter Seventeen: Palliative Care for Patients and Families With Parkinson's Disease - p. 474 12. Chapter Eighteen: Multidisciplinary Care in Parkinson's Disease - p. 509
Parkinson's Disease, Volume 132 addresses new developments in the F33 study of this disease, highlighting how the lives of people with Parkinson’s have undergone dramatic changes in the last decade. New to this edition are chapters on the Hallmarks of clinical aspects PD throughout centuries, The motor syndrome of Parkinson disease, The non-motor features of Parkinson’s disease, The New Diagnostic Criteria for Parkinson's disease, Advances in the Clinical Differential diagnosis, Clinical assessments in PD : Scales and monitoring, Biomarkers of Parkinson’s disease: an Introduction, and the Genetics of Parkinson’s Disease: Genotype-Phenotype Correlations.
The topics discussed in this comprehensive series provide a clearer understanding of the prodromal stage, genetics, strategies, routes of treatment, and development of non-dopaminergic therapies in Parkinson's Disease, both medical and surgical.
1. Chapter Seven: Biomarkers of Parkinson's Disease: An Introduction - p. 182 2. Chapter Eight: Genetics of Parkinson's Disease: Genotype–Phenotype Correlations - p. 196 3. Chapter Nine: Imaging in Parkinson's Disease - p. 231 4. Chapter Ten: Cerebrospinal Fluid Biomarkers of Cognitive Decline in Parkinson's Disease - p. 274 5. Chapter Eleven: Hallmarks of Treatment Aspects: Parkinson's Disease Throughout Centuries Including l-Dopa - p. 294 6. Chapter Twelve: Treatment Strategies in Early Parkinson's Disease - p. 343 7. Chapter Thirteen: Treatment of Nonmotor Symptoms in Parkinson's Disease - p. 360 8. Chapter Fourteen: Treatment of Older Parkinson's Disease - p. 379 9. Chapter Fifteen: New Symptomatic Treatments for the Management of Motor and Nonmotor Symptoms of Parkinson's Disease - p. 405 10. Chapter Sixteen: Device-Aided Treatment Strategies in Advanced Parkinson's Disease - p. 452 11. Chapter Seventeen: Palliative Care for Patients and Families With Parkinson's Disease - p. 474 12. Chapter Eighteen: Multidisciplinary Care in Parkinson's Disease - p. 509
